1. Home
  2. RDY vs NCLH Comparison

RDY vs NCLH Comparison

Compare RDY & NCLH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • NCLH
  • Stock Information
  • Founded
  • RDY 1984
  • NCLH 1966
  • Country
  • RDY India
  • NCLH United States
  • Employees
  • RDY N/A
  • NCLH N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • NCLH Marine Transportation
  • Sector
  • RDY Health Care
  • NCLH Consumer Discretionary
  • Exchange
  • RDY Nasdaq
  • NCLH Nasdaq
  • Market Cap
  • RDY 12.1B
  • NCLH 10.1B
  • IPO Year
  • RDY N/A
  • NCLH 2013
  • Fundamental
  • Price
  • RDY $13.79
  • NCLH $23.82
  • Analyst Decision
  • RDY Strong Buy
  • NCLH Buy
  • Analyst Count
  • RDY 2
  • NCLH 19
  • Target Price
  • RDY $16.95
  • NCLH $27.89
  • AVG Volume (30 Days)
  • RDY 1.5M
  • NCLH 15.2M
  • Earning Date
  • RDY 07-23-2025
  • NCLH 07-31-2025
  • Dividend Yield
  • RDY 0.52%
  • NCLH N/A
  • EPS Growth
  • RDY 2.20
  • NCLH 61.59
  • EPS
  • RDY 0.79
  • NCLH 1.54
  • Revenue
  • RDY $3,897,394,052.00
  • NCLH $9,560,994,000.00
  • Revenue This Year
  • RDY $7.61
  • NCLH $8.52
  • Revenue Next Year
  • RDY $1.89
  • NCLH $10.12
  • P/E Ratio
  • RDY $17.40
  • NCLH $15.58
  • Revenue Growth
  • RDY 15.86
  • NCLH 5.22
  • 52 Week Low
  • RDY $12.26
  • NCLH $14.21
  • 52 Week High
  • RDY $16.89
  • NCLH $29.29
  • Technical
  • Relative Strength Index (RSI)
  • RDY 40.12
  • NCLH 54.04
  • Support Level
  • RDY $13.32
  • NCLH $24.53
  • Resistance Level
  • RDY $14.86
  • NCLH $25.48
  • Average True Range (ATR)
  • RDY 0.23
  • NCLH 0.82
  • MACD
  • RDY -0.05
  • NCLH -0.18
  • Stochastic Oscillator
  • RDY 31.29
  • NCLH 18.26

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About NCLH Norwegian Cruise Line Holdings Ltd.

Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 70,000). It operates 33 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 12 passenger vessels on order among its brands through 2036, representing 37,500 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.

Share on Social Networks: